Dow Up 1.32% Nasdaq Up 1.60%

Salix Pharmaceuticals Ltd. (SLXP)

-NasdaqGS
135.56 2.05(1.49%) Oct 23, 4:00PM EDT
|After Hours : 135.59 Up 0.03 (0.02%) Oct 23, 4:42PM EDT
Prev Close:137.61
Open:139.22
Bid:135.50 x 100
Ask:N/A
1y Target Est:169.06
Beta:0.93
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:135.09 - 140.25
52wk Range:70.64 - 172.98
Volume:1,289,362
Avg Vol (3m):1,843,500
Market Cap:8.63B
P/E (ttm):150.12
EPS (ttm):0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SLXP

Comparison

Symbol% ChgMkt Cap
SLXPDown 1.49%8.63B
BAYRY111.64B
GSK108.95B
WCRXN/A

Key Statistics

Forward P/E (1 yr):19.23
P/S (ttm):6.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :6.16
Quarterly EPS Est (Sep-14) :1.56
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback